Bumper Offer - Urjas oil Just @ Rs. 1
Telsartan R 2.5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Telsartan R 2.5 Tablet is used -
Severe
Mild
Common
Is the use of Telsartan R 2.5 Tablet safe for pregnant women?
Telsartan R has many dangerous side effects in pregnant women. If you are pregnant, do not consume Telsartan R without medical advice.
Is the use of Telsartan R 2.5 Tablet safe during breastfeeding?
Telsartan R may have very limited harmful effects for breastfeeding women.
What is the effect of Telsartan R 2.5 Tablet on the Kidneys?
Telsartan R rarely harms the kidneys.
What is the effect of Telsartan R 2.5 Tablet on the Liver?
Telsartan R has very mild side effects on the liver.
What is the effect of Telsartan R 2.5 Tablet on the Heart?
Telsartan R has very mild side effects on the heart.
Telsartan R 2.5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Telsartan R 2.5 Tablet unless your doctor advises you to do so -
Is this Telsartan R 2.5 Tablet habit forming or addictive?
No, there is no any evidence that Telsartan R 2.5 Tablet is addictive.
Interaction between Food and Telsartan R 2.5 Tablet
When consumed with certain foods, Telsartan R 2.5 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Telsartan R 2.5 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Telsartan R 2.5 Tablet with alcohol will be.
Yes, Telsartan R causes hyperkalemia (high amount of potassium in the blood). Therefore, monitoring of blood potassium levels is important during Telsartan R therapy.
Telsartan R contains telmisartan which is an antihypertensive drug that works by preventing a chemical (angiotensin II) to bind with a receptor. This causes relaxation of blood vessels, it also prevents the synthesis and release of aldosterone (a hormone whose hyperactivity results in high blood pressure). In this way Telsartan R decreases the blood pressure.
Telsartan R is the brand name for telmisartan. It belongs to a group of medications known as angiotensin II receptor blockers. It is available in the form of tablets. Telsartan R is used to treat hypertension. It is also used to decrease cardiovascular risk in patients who cannot take ACE (angiotensin-converting enzyme) inhibitors.
Telsartan R is available in the form of tablets. A tablet is usually taken once a day, with or without food because food affects the absorption of this drug. It should be taken at exactly the same time every time to avoid skipping the dose. Telsartan R might start showing the effects between 2 to 4 weeks, therefore, it is important to continue taking it even when you feel well. One should take Telsartan R exactly as prescribed by their doctor.
Yes, Telsartan R causes hyponatremia (low level of sodium in the blood). Treatment with telmisartan might call for a regular blood monitoring for checking sodium levels.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503